Stephen Ubl, president and chief executive officer of PhRMA (Photographer: Andrew Harrer/Bloomberg via Getty Images)

Two sides of 'his­toric' drug pric­ing bill: Phar­ma in­dus­try blasts 'mis­take' while ad­vo­cates plan for 'first ever' gains

Both Con­gres­sion­al De­moc­rats and the phar­ma in­dus­try agree that pend­ing drug pric­ing leg­is­la­tion is “his­toric” — they just di­a­met­ri­cal­ly dis­agree on the mod­i­fi­er.

Trade in­dus­try group PhRMA’s CEO Stephen Ubl called it an “his­toric mis­take” on Wednes­day, joined by Eli Lil­ly CEO David Ricks, At­las Ven­ture part­ner Jean-Fran­cois Formela along with a hema­tol­ogy on­col­o­gy-lead­ing physi­cian and a metasta­t­ic breast can­cer sur­vivor in a press con­fer­ence.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.